1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Specialty Pharmaceuticals Market
3.2. Opportunities in the Specialty Pharmaceuticals Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Spain Specialty Pharmaceuticals Market: Type Estimates & Trend Analysis
5.1. Overview
5.2. Market Sizing & Forecasting
6. Spain Specialty Pharmaceuticals Market: Product Estimates & Trend Analysis
6.1. Overview
6.2. Market Sizing & Forecasting
7. Spain Specialty Pharmaceuticals Market: Distribution Channel Estimates & Trend Analysis
7.1. Overview
7.2. Market Sizing & Forecasting
8. Competitive Landscape
8.1. 360iResearch FPNV Positioning Matrix for Spain Specialty Pharmaceuticals Market
8.2. Market Vendor Ranking Analysis for Spain Specialty Pharmaceuticals Market
8.3. Competitive News Feed Analysis for Spain Specialty Pharmaceuticals Market
8.3.1. Mergers & Acquisitions
8.3.2. New Product Launches
8.3.3. Business Expansions
8.3.4. Partnerships, Agreements & Collaborations
9. Company Usability Profiles
9.1. CVS Health Corporation
9.1.1. Business Overview
9.1.2. FPNV Scorecard
9.1.3. Business SWOT
9.1.4. Business Strategy
9.2. Endo Pharmaceuticals Inc.
9.2.1. Business Overview
9.2.2. FPNV Scorecard
9.2.3. Business SWOT
9.2.4. Business Strategy
9.3. Kroger Specialty Pharmacy, Inc.
9.3.1. Business Overview
9.3.2. FPNV Scorecard
9.3.3. Business SWOT
9.3.4. Business Strategy
9.4. McKesson Corporation
9.4.1. Business Overview
9.4.2. FPNV Scorecard
9.4.3. Business SWOT
9.4.4. Business Strategy
9.5. Midatech Pharma PLC
9.5.1. Business Overview
9.5.2. FPNV Scorecard
9.5.3. Business SWOT
9.5.4. Business Strategy
9.6. Allergan plc
9.6.1. Business Overview
9.6.2. FPNV Scorecard
9.6.3. Business SWOT
9.6.4. Business Strategy
9.7. Chiesi Farmaceutici SpA
9.7.1. Business Overview
9.7.2. FPNV Scorecard
9.7.3. Business SWOT
9.7.4. Business Strategy
9.8. CIGNA
9.8.1. Business Overview
9.8.2. FPNV Scorecard
9.8.3. Business SWOT
9.8.4. Business Strategy
9.9. Nordic Pharma Group
9.9.1. Business Overview
9.9.2. FPNV Scorecard
9.9.3. Business SWOT
9.9.4. Business Strategy
9.10. RECORDATI S.p.A.
9.10.1. Business Overview
9.10.2. FPNV Scorecard
9.10.3. Business SWOT
9.10.4. Business Strategy
9.11. Sun Pharmaceutical Industries Ltd.
9.11.1. Business Overview
9.11.2. FPNV Scorecard
9.11.3. Business SWOT
9.11.4. Business Strategy
9.12. Walgreens Boots Alliance, Inc.
9.12.1. Business Overview
9.12.2. FPNV Scorecard
9.12.3. Business SWOT
9.12.4. Business Strategy
10. Appendix
10.1. Discussion Guide
10.2. Top Reports
10.3. Author Details